Abstract
HER2 oncogene overexpression has been associated either with proliferation or differentiation and apoptosis. The role of p53 on these different chances was investigated. Wild type (wt) p53-IGROV1 cells showed growth inhibition and apoptosis after HER2 transfection, whereas no anti-proliferative effect was observed in its mutated p53 sub-line unless wt p53 was cotransfected with HER2. Stable HER2 transfectants derived from wt p53 line treated with heregulin-β1 or epidermal growth factor showed a decrease in proliferation due to a G2/M cell cycle block despite normal mitogen-activated protein kinase activation. In these HER2 transfectants, c-Myc and p53 expression were increased, whereas MDM2 was dramatically down-modulated. By contrast, growth factors stimulation of HER2 transfectants with mutated-p53 induced progression through the cell cycle. Together, our data point to a regulatory role for p53 in HER2 signaling.
Cite
CITATION STYLE
Casalini, P., Botta, L., & Ménard, S. (2001). Role of p53 in HER2-induced Proliferation or Apoptosis. Journal of Biological Chemistry, 276(15), 12449–12453. https://doi.org/10.1074/jbc.M009732200
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.